Articles From: Cardinal Financial Corporation Announces Plans to Acquire Gainesville Office of Virginia Heritage Bank to Cardtronics Announces Pricing of $250 Million Private Offering of Senior Notes


Cardinal Financial Corporation (Nasdaq: CFNL) (“Cardinal” or the “Company”), the holding company of Cardinal Bank, announced today that Cardinal Bank has signed a definitive agreement with EagleBank to acquire the current Gainesville, Virginia branch office of Virginia Heritage Bank.
Sign-up for Cardinal Financial Corporation Announces Plans to Acquire Gainesville Office of Virginia Heritage Bank investment picks
Cardinal Financial Corporation (NASDAQ: CFNL) (the “Company”) today announced that its Board of Directors has declared its quarterly cash dividend of $0.08 per share.
Sign-up for Cardinal Financial Corporation Declares Quarterly Dividend investment picks
2014/7/25
Winners are hometown pharmacies from Ohio, Tennessee and Texas WASHINGTON , July 25, 2014 /PRNewswire/ -- Cardinal Health will today name three of the nation's most innovative community pharmacies as winners of its prestigious Independent Pharmacy Best Practices Competition, during the company's Retail Business Conference , one of the nation's largest gatherings of independent pharmacists.
Sign-up for Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy investment picks
WASHINGTON , July 23, 2014 /PRNewswire/ -- Nearly 8,000 attendees will converge in Washington D.C. for Cardinal Health's annual Retail Business Conference (RBC), taking place July 23-26 at the Gaylord National Resort & Convention Center.
Sign-up for Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference investment picks
By Chelsey Dulaney Cardinal Health Inc. (CAH) on Thursday named Michael Kaufmann, who heads the drug distributor's pharmaceutical unit, as the company's chief financial officer.
Sign-up for Cardinal Health Names New Finance Chief investment picks
2014/8/4
-- Non-GAAP1 diluted earnings per share from continuing operations increased 5 percent to $0.83 per share for the fourth quarter and 3 percent to $3.84 per share for fiscal 2014 --
Sign-up for Cardinal Health Reports Fourth-Quarter And Fiscal Year Results, Provides Fiscal 2015 Outlook investment picks
2014/7/7
Company has donated nearly $4.2 million to more than 20 universities through its nationwide pharmacy scholarship program, now in its fourth year DUBLIN, Ohio , July 7, 2014 /PRNewswire/ -- As part of its continued commitment to supporting future pharmacists, Cardinal Health today announced that nine pharmacy schools across the country will collectively receive $2 million in funding through the Cardinal Health Pharmacy Scholarship Program in 2014.
Sign-up for Cardinal Health Supports Future Pharmacists with $2 Million in Scholarships investment picks
2014/7/1
DUBLIN, Ohio , July 1, 2014 /PRNewswire/ -- Cardinal Health plans to release fourth-quarter and full-year financial results for its fiscal 2014 on August 4 , prior to the opening of trading on the New York Stock Exchange.
Sign-up for Cardinal Health To Release Fourth-Quarter And Full-Year Results For Fiscal Year 2014 On Aug. 4 investment picks
NEW YORK (MarketWatch) -- Cardinal Health Inc. (CAH) said it earned $234 million, or 68 cents a share, in its fiscal fourth quarter, after a loss of $586 million, or $1.72 a share, in the same period a year ago when it booked a goodwill impairment charge relating to its nuclear division.
Sign-up for Cardinal Health tops profit, sales estimates investment picks
2014/7/18
NASDAQ: CRME, TSX: COM VANCOUVER , July 18, 2014 /PRNewswire/ - Cardiome Pharma Corp.
Sign-up for Cardiome announces closing of senior, secured term loan facility investment picks
2014/7/18
Cardiome announces closing of senior, secured term loan facility Canada NewsWire NASDAQ: CRME, TSX: COM VANCOUVER , July 18, 2014 /CNW/ - Cardiome Pharma Corp.
Sign-up for Cardiome announces closing of senior, secured term loan facility investment picks
2014/8/25
Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS™ In Argentina Canada NewsWire NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS™ In Argentina investment picks
2014/8/25
NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome Enters Commercialization Agreement With Eurolab Especialidades Medicinales For BRINAVESS™ In Argentina investment picks
2014/8/11
NASDAQ: CRME TSX: COM Cardiome to conduct conference call and webcast today, August 11 , at 8:00 a.m. Eastern ( 5:00 a.m. Pacific) VANCOUVER , Aug.
Sign-up for Cardiome Reports Second Quarter 2014 Financial Results investment picks
NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome Submits BRINAVESS Dossier to French Authorities to Support Market Access investment picks
2014/8/5
NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome Submits BRINAVESS Reimbursement Dossier to Belgian Authorities investment picks
2014/8/5
NASDAQ: CRME, TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome to hold second quarter 2014 financial results conference call on August 11 investment picks
2014/8/6
NASDAQ: CRME TSX: COM VANCOUVER , Aug.
Sign-up for Cardiome To Present At Canaccord Genuity Growth Conference On August 13 investment picks
2014/6/19
NASDAQ: CRME TSX: COM VANCOUVER , June 19, 2014 /PRNewswire/ - Cardiome Pharma Corp.
Sign-up for Cardiome to Present at JMP Securities Healthcare Investor Conference investment picks
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced that the Center for Medicare and Medicaid Services (CMS) has approved a New Technology Add-on Payment (NTAP) for the CardioMEMS ™ HF System .
Sign-up for CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment investment picks
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII), unveiled new data about the treatment of arterial calcification at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington D.C. Arterial calcium is a common occurrence for the millions of patients suffering from peripheral artery disease (PAD) and it can lead to significant complications.
Sign-up for Cardiovascular Systems Releases New Peripheral Data at 2014 TCT Conference investment picks
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal fourth quarter and year ended June 30, 2014.
Sign-up for Cardiovascular Systems Reports Fiscal 2014 Fourth-Quarter and Full-Year Financial Results investment picks
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal fourth quarter ended June 30, 2014, and its financial outlook.
Sign-up for Cardiovascular Systems to Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6 investment picks
Taxus Cardium Pharmaceuticals Group Inc. (OTCQB: CRXM) will report today at the Biotechnology Industry Organization’s 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx ® Ad5FGF-4, Cardium Therapeutics’ angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.
Sign-up for Cardium Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy of Generx® Angiogenic Gene Therapy for Myocardial Ischemia Due to Coronary Artery Disease at the 2014 BIO International Convention investment picks
2014/6/24
Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO , June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx ® Ad5FGF-4, Cardium Therapeutics' angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.
Sign-up for Cardium Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy of Generx® Angiogenic Gene Therapy for Myocardial Ischemia Due to Coronary Artery Disease at the 2014 BIO International Convention investment picks
Joint Venture Companies to Provide Architectural, Engineering, and Environmental Services for the Tactical Training Theater Assessment and Planning Program CHARLOTTESVILLE, Va.
Sign-up for Cardno TEC-Leidos Joint Venture Awarded Contract By Naval Facilities Engineering Command Atlantic investment picks
HOUSTON, July 14, 2014 (GLOBE NEWSWIRE) -- Cardtronics, Inc. (Nasdaq:CATM) , the world's largest retail ATM owner, today announced that subject to market conditions, it intends to offer $250 million in aggregate principal amount of senior notes due 2022 for sale to eligible purchasers in a private offering (the "Notes Offering"). Cardtronics intends to use the net proceeds from the Notes Offering to purchase all of its outstanding $179,442,000 aggregate principal amount of 8.250% senior subordinated notes due 2018 pursuant to a tender offer, to redeem any such notes not acquired in the tender offer and for general corporate purposes.
Sign-up for Cardtronics Announces $250 Million Private Offering of Senior Notes investment picks
HOUSTON, July 14, 2014 (GLOBE NEWSWIRE) -- Cardtronics, Inc. (Nasdaq:CATM) , the world's largest retail ATM owner, today announced the pricing of $250 million in aggregate principal amount of 5.125% senior notes due 2022 at par for sale to eligible purchasers in a private offering (the "Notes Offering"). The Notes Offering is expected to close on July 28, 2014, subject to customary closing conditions.
Sign-up for Cardtronics Announces Pricing of $250 Million Private Offering of Senior Notes investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Cardinal Financial Corporation Announces Plans to Acquire Gainesville Office of Virginia Heritage Bank to Cardtronics Announces Pricing of $250 Million Private Offering of Senior Notes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices